Echocardiographic pattern of left ventricular function recovery in tachycardia-induced cardiomyopathy patients

Teodor Serban1,2, Jeanne du Fay de Lavallaz1,2, Diego Mannhart1,2

  • 1Department of Cardiology, University Hospital Basel, Basel, Switzerland.

ESC Heart Failure
|May 23, 2023
PubMed

Insights

Tachycardia-induced cardiomyopathy (TCM) patients show persistent cardiac remodeling and worse functional recovery compared to other cardiomyopathies. Echocardiographic markers can help identify TCM, which is often underdiagnosed.

Area of Science:

  • Cardiology
  • Cardiovascular Diseases
  • Cardiac Imaging

Background:

  • Tachycardia-induced cardiomyopathy (TCM) is a partially reversible condition often underdiagnosed.
  • Cardiac chamber remodeling in TCM is not fully understood.
  • This study compares TCM with other cardiomyopathies (CM).

Purpose of the Study:

  • To explore differences in left ventricle dimensions and functional recovery in TCM patients versus other CM.
  • To identify predictors for TCM diagnosis.

Main Methods:

  • Retrospective analysis of 238 patients with reduced ejection fraction and/or atrial fibrillation.
  • Patients divided into TCM and control groups.
  • Echocardiographic parameters including LVEDVI, fractional shortening, and LAVI were analyzed.

Main Results:

  • TCM patients showed no significant improvement in indexed left ventricular end-diastolic volume (LVEDVI) post-treatment.
  • TCM patients had worse baseline fractional shortening and higher baseline/follow-up indexed left atrial volume (LAVI).
  • Predictors for TCM included normal LVEDVI, fractional shortening <30%, LAVI >40 mL/m², and normal left ventricle wall thickness.

Conclusions:

  • TCM patients exhibit distinct functional recovery patterns with persistent left atrial and ventricular remodeling.
  • Echocardiographic parameters may aid in pre-treatment TCM identification.
  • TCM is associated with a higher incidence of persistent heart failure symptoms.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
17